Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
MIMEDX GROUP, INC. (MDXG)
|
Add to portfolio |
|
|
|
| Price: |
$6.27
| | Metrics |
| OS: |
114.1
|
M
| |
-49
|
% ROE
|
| Market cap: |
$715
|
M
| |
-64
|
% ROIC
|
|
Net cash:
|
$17.4
|
M
| |
$0.15
|
per share
|
|
EV:
|
$698
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($20.9)
|
M
| |
|
|
|
EBIT
|
($25.0)
|
M
| |
|
|
| EPS |
($0.33)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 267.8 | 258.6 | 248.2 | 299.3 | 359.1 | 321.1 | 221.7 | 187.3 |
| Revenue growth | 3.6% | 4.2% | -17.0% | -16.7% | 11.8% | 44.8% | 18.4% | 58.4% |
| Cost of goods sold | 48.3 | 43.3 | 39.3 | 43.1 | 36.4 | 35.2 | 30.9 | 20.2 |
| Gross profit | 219.5 | 215.3 | 208.9 | 256.2 | 322.7 | 285.9 | 190.8 | 167.1 |
| Gross margin | 82.0% | 83.3% | 84.2% | 85.6% | 89.9% | 89.0% | 86.0% | 89.2% |
| Selling, general and administrative | 208.8 | 198.4 | 181.0 | 198.2 | 258.5 | 220.1 | 173.4 | 133.4 |
| Research and development | 22.8 | 17.3 | 11.7 | 11.1 | 15.8 | 17.9 | 14.3 | 8.4 |
| EBITA | -24.3 | -4.2 | -43.3 | -19.7 | -2.9 | 47.9 | 3.0 | 25.3 |
| EBITA margin | -9.1% | -1.6% | -17.4% | -6.6% | -0.8% | 14.9% | 1.4% | 13.5% |
| Amortization of intangibles | 0.7 | 0.8 | 1.1 | 1.0 | 1.0 | 1.7 | 2.1 | 0.9 |
| EBIT | -25.0 | -5.0 | -44.4 | -20.7 | -3.9 | 46.2 | 0.9 | 24.4 |
| EBIT margin | -9.3% | -1.9% | -17.9% | -6.9% | -1.1% | 14.4% | 0.4% | 13.0% |
| Pre-tax income | -30.0 | -10.0 | -61.5 | -25.6 | -3.4 | 45.1 | 0.5 | 24.3 |
| Income taxes | 0.2 | 0.2 | -12.3 | 0.0 | 26.6 | -19.6 | 0.2 | -5.2 |
| Tax rate | | | 19.9% | 0.0% | | | 28.4% | |
| Net income | -36.8 | -16.4 | -83.3 | -25.6 | -30.0 | 64.7 | 0.4 | 29.4 |
| Net margin | -13.7% | -6.3% | -33.6% | -8.5% | -8.3% | 20.2% | 0.2% | 15.7% |
| |
| Diluted EPS | ($0.33) | ($0.15) | ($0.77) | ($0.24) | ($0.28) | $0.56 | $0.00 | $0.26 |
| Shares outstanding (diluted) | 112.9 | 110.4 | 108.3 | 106.9 | 105.6 | 116.1 | 112.6 | 113.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|